- Human Suppression Of Tumorigenicity 14 (ST14) Protein
- Abbexa Ltd
- Pricing InfoSupplier PageView Company Product Page
- abx069206
- 10 µg, 50 µg, 100 µg, 200 µg, 1 mg
- WB, SDS-PAGE
- Unconjugated
- Calculated MW: 33.9 kDa
Observed MW (SDS-PAGE): 33 kDa - Suppression Of Tumorigenicity 14 (ST14)
- ST14 transmembrane serine protease matriptase
- ARCI11, CAP3, HAI, MT-SP1, MTSP1, PRSS14, SNC19, TADG15, TMPRSS14
- > 97%
- Prior to lyophilization: 200 µg/ml
- Lyophilized, Prior to lyophilization: 20 mM Tris, 150 mM NaCl, pH 8.0, containing 1 mM EDTA, 1 mM DTT, 0.01% Sarcosyl, 5% Trehalose and Proclin-300
- E. coli
- Human
- Store at 2-8 °C for up to one month. Store at -80 °C for up to one year. Avoid repeated freeze/thaw cycles
Sequence
RSFTRQARVV GGTDADEGEW PWQVSLHALG QGHICGASLI SPNWLVSAAH CYIDDRGFRY SDPTQWTAFL GLHDQSQRSA PGVQERRLKR IISHPFFNDF TFDYDIALLE LEKPAEYSSM VRPICLPDAS HVFPAGKAIW VTGWGHTQYG GTGALILQKG EIRVINQTTC ENLLPQQITP RMMCVGFLSG GVDSCQGDSG GPLSSVEADG RIFQAGVVSW GDGCAQRNKP GVYTRLPLFR DWIKEN